期刊文献+

处方评价工作存在问题探讨 被引量:14

Discussion on Problems in Prescription Evaluation
下载PDF
导出
摘要 目的:探讨处方点评制度中存在的问题,落实《处方管理办法》。方法:分析本院开展处方评价工作的情况,就处方指标、抽样方法及评价标准三个方面提出意见和建议。结果:处方评价指标应作适当调整,增加住院用药调研指标,并推广"人均"概念;不同的处方抽样方法和样本量对统计结果有影响,采用分层按比例抽样,再按总体概率最低值计算样本量较为合理;处方评价缺乏科学合理的比较标准,应统一制订国家标准。结论:处方评价工作还需进一步提高科学性和可操作性。 Objective: To discuss the problems in the system of prescription evaluation and carry out'Prescription Administrative Policy' (PAP). Methods: The problems on practice of prescription evaluation in our hospital were analyzed, and the comments and suggestions were proposed on the indexes of prescription evaluation, the prescription sampling methods and the standard of prescription evaluation. Results: The parameters of prescription evaluation should be appropriately adjusted. The medication research on inpatients should be listed in the system of evaluation and the concept of 'per capita' should be promoted. The different sampling methods and sample size had influence on the results. It is more scientific and reasonable to use stratified random sampling method and take the minimum value of the overall probability to estimate the minimum sample size. Scientific and reasonable standard of prescription evaluation is deficient, therefore national standard should be formulated by Ministry of Health. Conclusion: Scientific and feasible prescription evaluation system should be further enhanced.
机构地区 解放军第
出处 《中国药物应用与监测》 CAS 2009年第5期313-315,共3页 Chinese Journal of Drug Application and Monitoring
关键词 处方管理办法 处方评价 合理用药 选择性用药指标 Prescription administrative policy Prescription evaluation Rational drug use Selected drug use indicators (SDUI)
  • 相关文献

参考文献4

二级参考文献14

共引文献233

同被引文献76

  • 1张志清.国内抗菌药物应用现状及实施抗菌药物合理应用干预的可行性与难点[J].中国药房,2004,15(12):708-710. 被引量:111
  • 2李洋,颜虹.处方信息的分析和利用[J].中国医院统计,2005,12(1):79-82. 被引量:228
  • 3王海莲,张建华,许银慧,李杰,褚燕琦,李晓丹,李森.浅谈住院药房药师如何为临床开展药学服务[J].中国药房,2007,18(7):558-559. 被引量:14
  • 4中华医学会心血管病学分会,《中华心血管病杂志》编辑委员会.慢性心力衰竭诊断治疗指南(2007年).
  • 5处方管理办法[s].卫生部令第53号,2006.
  • 6卫生部.关于印发《医院处方点评管理规范(试行)》的通知[z].卫医管发[2010]28号,2010.
  • 7Phillips MS, Gayman JE, Todd MW. ASHP guidelines on medication-use evaluation [J]. American Society of Healthsystem Pharmacists. Am J Health Syst Pharm, 1996, 53 (16) : 1953-1955.
  • 8Vermeulen LC, Beis SJ, Cano SB. Applying outcomes research in improving the medication-use process [J] . Am J Health Syst Pharm, 2000, 57 (24): 2277-2282.
  • 9Schrand LM, Behmer-Miller KA, Ross MB, et al. Medication use evaluation: a work in progress [J] . Pharm Pract Manag Q, 2000, 20 (2): 1-15.
  • 10Avorn J. Post-modern drug evaluation. The deconstruction of evidence-based regulation [ J ] . Pharmacoeconomics, 2000, 18 Suppl 1: 15-20.

引证文献14

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部